COMPANY PRESENTATION
Conference Call
H1 2026 Financial results Sept. 11th, 2026
Certain statements inthisslide show, including those addressing theCompany’s beliefs, plans, objectives, estimates or expectations ofpossible future results orevents, are forward -looking statements .Forward -looking statements involve known orunknown risks, including general economic and business conditions, and conditions inthe industry weoperate and may beaffected should our assumptions turn out tobeinaccurate .Consequently, no forward -looking statement can beguaranteed and actual future results, performance, orachievements may vary materially from those expressed orimplied bysuch forward -looking statements .The Company undertakes no obligation about the contents nor toupdate the forward -looking statements toreflect events orcircumstances that may arise after thedate hereof .
2 DISCLAIMER
Highlights –H12026 3 2026 Financials - Euro '000 P&L 30/06/2025 % 30/06/2026 % Var.% Revenues 225.903 246.454 9,1%
EBIT 31.558 14,0% 43.436 17,6% 37,6%
Revenues 30/06/2025 % 30/06/2026 % Var.% Medical 206.131 91,2% 227.501 92,3% 10,4% Industrial 19.772 8,8% 18.953 7,7% -4,1% P&L (w/o IFRS5) 30/06/2025 % 30/06/2026 % Var.%
unaudited
Revenues 285.336 300.101 5,2%
EBIT 34.649 12,1% 44.926 15,0% 29,7%
Income Statement 4 Euro '000 30/06/2025 % 30/06/2026 % Var. % Medical 206.131 91,2% 227.501 92,3% 10,4% Industrial 19.772 8,8% 18.953 7,7% -4,1% Revenues 225.903 100,0% 246.454 100,0% 9,1% Gross margin 109.195 48,3% 122.779 49,8% 12,4% Operating Expenses 26.563 11,8% 26.897 10,9% 1,3% Staff espenses 45.148 20,0% 47.149 19,1% 4,4%
EBITDA 37.484 16,6% 48.734 19,8% 30,0%
Depr., amort., accruals 5.926 2,6% 5.298 2,1% -10,6%
EBIT 31.558 14,0% 43.436 17,6% 37,6%
Net financ.income(charges) (2.009) -0,9% 1.714 0,7% Other income (expense) net (205) -0,1% (1.761) -0,7% 758,8%
EBT 29.344 13,0% 43.389 17,6% 47,9%
Income taxes (9.504) -4,2% (13.703) -5,6% 44,2% Discontinued operations (2.568) -1,1% (2.487) -1,0% -3,1% Minorities 660 0,3% (1.101) -0,4%
NET INCOME 17.932 7,9% 26.098 10,6% 45,5%
31/12/25 30/06/26
Net financial position 172.212 184.515
Income Statement w/o IFRS5 5 Euro '000 30/06/2025 % 30/06/2026 % Var. %
unaudited
Medical 206.131 72,2% 227.501 75,8% 10,4% Industrial 79.205 62,8% 72.600 24,2% -8,3% Revenues 285.336 100,0% 300.101 100,0% 5,2% Gross margin 126.211 44,2% 138.061 46,0% 9,4% Operating Expenses 30.943 10,8% 30.641 10,2% -1,0% Staff espenses 53.045 18,6% 55.241 18,4% 4,1%
EBITDA 42.223 14,8% 52.180 17,4% 23,6%
Depr., amort., accruals 7.574 2,7% 7.254 2,4% -4,2%
EBIT 34.649 12,1% 44.926 15,0% 29,7%
Net financ.income(charges) (2.662) -0,9% 1.836 0,6% Other income (expense) net (261) -0,1% (1.771) -0,6% 578,0%
EBT 31.726 11,1% 44.991 15,0% 41,8%
Income taxes (10.408) -3,6% (13.543) -4,5% 30,1% Discontinued operations (4.046) -1,4% (4.248) -1,4% 5,0% Minorities 660 0,2% (1.101) -0,4%
NET INCOME 17.932 6,3% 26.098 8,7% 45,5%
31/12/25 30/06/26
unaudited
Net financial position 172.212 161.196
Balance Sheet 6 Euro '000 31/12/25 30/06/26 Var.% Total non current assets 118.766 99.904 -15,9% Net Working Capital 184.586 153.936 -16,6% Other receivables/payables ST (31.183) (25.784) -17,3% Net financial position 172.212 184.515 7,1% Long term liabilities 16.907 14.251 -15,7% Net Equity 427.474 435.607 1,9% Discontinued operation 0 37.288 Net capital employed 255.262 251.092 -1,6% Net Working Capital on sales 31,2% 31,2%
ROCE
(EBIT/Net capital employed)30,5% 34,6% Operating Capex 19.376 7.476
Cash Flow –H1 2026 7
15 mln
* Nopat =Ebit-Income tax **D&A= Depreciation, Accruals and Devaluation ***NWC= Net Working Capital 21 mln7,5 mln16 mln
Revenue Breakdown by Business 8
Medical: +10%
Industrial : -4%in Euro million +11%
+15%
+1%+2%
-17%
-15%+34%
Revenue Breakdown by Area 9 in Euro million
-16%+17%
+8%+8%
-15%
+1%Medical: +10%
Industrial : -4%
10 2026 Guidance Revenues increase >+5%
EBIT %2026 >EBIT %2025
CONTACTS
El.En . S.P.A.
Enrico Romagnoli
Investor Relations Manager tel. +39 055 -8826807
E-mail: finance@elen.it
POLYTEMS HIR
Financial Communication, IR and Press Office Bianca Fersini Mastelloni -b.fersini@polytemshir.it Silvia Marongiu -s.marongiu@polytemshir.it Tel. +39 06 -69923324